ApoB to ApoA1 Ratio (ApoB/ApoA1)
The ApoB/ApoA1 ratio reflects the exact biological balance between circulating atherogenic particles (ApoB) and protective reverse-transport particles (ApoA1).
Standard vs. Optimal Reference Rangesratio
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
< 0.80 (Male), < 0.70 (Female)
General reference distribution across unselected commercial populations.
< 0.50
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
A high ratio signifies an overabundance of atherogenic particles relative to the clearance capacity of functional HDL, predisposing the arterial subendothelium to lipid accumulation and plaque rupture.
Differential Diagnosis
Elevated Levels (ApoB/ApoA1 High)
- •High atherogenic burden / Accelerated vascular senescence
- •Metabolic syndrome
Low Levels (ApoB/ApoA1 Low)
- •Favorable vascular longevity profile with high reverse cholesterol transport
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Standard testing requires a 10 to 12 hour overnight fast to minimize postprandial chylomicron interference, although ApoB/ApoA1 direct immunoassay is less sensitive to prandial state than calculated LDL-C. Avoid strenuous high-intensity exercise 24 hours prior to blood draw. Serum separator tubes (SST) or EDTA plasma should be centrifuged within 2 hours. High-dose biotin (>5 mg/day) supplementation may interfere with competitive streptavidin-biotin immunoassays, requiring a 48-hour washout period.
Reflexive Testing Protocol:
- Advanced Lipoprotein Particle Quantification (NMR spectroscopy or ion mobility LDL-P)
- Lipoprotein(a) [Lp(a)] baseline evaluation for genetic cardiovascular risk stratification
- Coronary Artery Calcium (CAC) score via non-contrast cardiac CT to evaluate calcified plaque burden
- High-sensitivity C-Reactive Protein (hs-CRP) to assess systemic vascular inflammatory tone
- Carotid intima-media thickness (CIMT) duplex ultrasound to assess subclinical atherosclerosis
Clinical Citations & Primary Literature (1)
- [1]Effect of Potentially Modifiable Risk Factors Associated with Myocardial Infarction in 52 Countries (INTERHEART) - Lancet (2004). PMID: 15364185
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate ApoB to ApoA1 Ratio (ApoB/ApoA1) into overall healthspan optimization.